Progress towards elimination goals for viral hepatitis

被引:0
|
作者
Andrea L. Cox
Manal H. El-Sayed
Jia-Horng Kao
Jeffrey V. Lazarus
Maud Lemoine
Anna S. Lok
Fabien Zoulim
机构
[1] Johns Hopkins University,Department of Medicine
[2] Ain Shams University,Department of Paediatrics
[3] National Taiwan University Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine
[4] National Taiwan University College of Medicine,Graduate Institute of Clinical Medicine
[5] University of Barcelona,Barcelona Institute for Global Health (ISGlobal), Hospital Clínic
[6] Imperial College London,Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Hepatology section
[7] St Mary’s Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine
[8] University of Michigan,undefined
[9] Medical School,undefined
[10] Lyon University,undefined
[11] Hepatology Department,undefined
[12] Hospices Civils de Lyon,undefined
[13] Viral Hepatitis Research Laboratory,undefined
[14] CRCL – INSERM U1052,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The global burden of viral hepatitis is substantial; in terms of mortality, hepatitis B virus and hepatitis C virus infections are on a par with HIV, malaria and tuberculosis, among the top four global infectious diseases. In 2016, the 194 Member States of the World Health Organization committed to eliminating viral hepatitis as a public health threat by 2030, with a particular focus on hepatitis B virus and hepatitis C virus infection. With only 10 years to go until the 2030 deadline is reached, and although much progress has been made towards elimination, there are still some important gaps in terms of policy and progress. In this Viewpoint, we asked a selection of scientists and clinicians working in the viral hepatitis field for their opinions on whether elimination of viral hepatitis by 2030 is feasible, what the key areas of progress are and what the focus for the next 10 years and beyond should be for viral hepatitis elimination.
引用
收藏
页码:533 / 542
页数:9
相关论文
共 50 条
  • [1] Progress towards elimination goals for viral hepatitis
    Cox, Andrea L.
    El-Sayed, Manal H.
    Kao, Jia-Horng
    Lazarus, Jeffrey V.
    Lemoine, Maud
    Lok, Anna S.
    Zoulim, Fabien
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (09) : 533 - 542
  • [2] Creating evidence basis to monitor progress of viral hepatitis elimination goals in Germany
    Leendertz, S. A.
    Steffen, G.
    Sarma, N.
    Beermann, S.
    Schmitz, R.
    Bremer, V.
    Zimmermann, R.
    Dudareva, S.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 96 - 96
  • [3] Towards Elimination of Viral Hepatitis
    Davila, Mila Gonzalez
    Polanco, Victor Puac
    Santaella, Julian
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2016, 106 (08) : 1350 - 1350
  • [4] Editorial: Precision medicine in viral hepatitis: progress and prospects towards elimination
    Fernandez-Rodriguez, Amanda
    Valva, Pamela
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [5] Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update
    Cooke, Graham S.
    Flower, Barnaby
    Cunningham, Evan
    Marshall, Alison D.
    Lazarus, Jeffrey, V
    Palayew, Adam
    Jia, Jidong
    Aggarwal, Rakesh
    Al-Mahtab, Mamum
    Tanaka, Yashuito
    Jeong, Sook-Hyang
    Poovorawan, Kittiyod
    Waked, Imam
    Hiebert, Lindsey
    Khue, Pham M.
    Grebely, Jason
    Alcantara-Payawal, Diana
    Sanchez-Avila, Juan F.
    Mbendi, Charles
    Muljono, David H.
    Lesi, Olufunmilayo
    Desalegn, Hailemichael
    Hamid, Saeed
    de Araujo, Alexandre
    Cheinquer, Hugo
    Onyekwere, Charles A.
    Malyuta, Ruslan
    Ivanchuk, Iryna
    Thomas, David L.
    Pimenov, Nikolay
    Chulanov, Vladimir
    Dirac, Mae Ashworth
    Han, Hannah
    Ward, John W.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (04): : 346 - 365
  • [6] Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update
    Cooke, Graham S.
    Flower, Barnaby
    Cunningham, Evan
    Marshall, Alison
    Lazarus, Jeffrey, V
    Palayew, Adam
    Jia, Jidong
    Aggarwal, Rakesh
    Al-Mahtab, Mamum
    Tanaka, Yashuito
    Jeong, Sook-Hyang
    Poovorawan, Kittiyod
    Waked, Imam
    Hiebert, Lindsey
    Khue, Pham M.
    Grebely, Jason
    Alcantara-Payawal, Diana
    Sanchez-Avila, Juan F.
    Mbendi, Charles
    Muljono, David H.
    Lesi, Olufunmilayo
    Desalegn, Hailemichael
    Hamid, Saeed
    de Araujo, Alexandre
    Cheinquer, Hugo
    Onyekwere, Charles A.
    Malyuta, Ruslan
    Ivanchuk, Iryna
    Thomas, David L.
    Pimenov, Nikolay
    Chulanov, Vladimir
    Dirac, Mae Ashworth
    Han, Hannah
    Ward, John W.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (02): : 346 - 365
  • [7] Towards elimination of viral hepatitis by 2030
    不详
    LANCET, 2016, 388 (10042): : 308 - 308
  • [8] Progress towards elimination of viral hepatitis by 2030 in the WHO Eastern Mediterranean Region, 2019
    Alaama, Ahmed Sabry
    Khattabi, Hamida
    Mugisa, Bridget
    Atta, Hoda
    Hermez, Joumana
    Hutin, Yvan J.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (09): : 862 - 870
  • [9] Assessing progress towards viral hepatitis B and C elimination in prisons in the European region
    Fondelli, S.
    Pisetta, R.
    Mazzilli, S.
    Montanari, M. L.
    Seyler, T.
    Silva, F. Azevedo e
    Tavoschi, L.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34
  • [10] Progress towards elimination of hepatitis C in the UK
    Burki, Talha
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (04): : 303 - 303